Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01800903
Other study ID # CP235
Secondary ID CP235
Status Completed
Phase N/A
First received
Last updated
Start date February 2013
Est. completion date April 2013

Study information

Verified date August 2020
Source Coloplast A/S
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate safety and performance of a new catheter coating,compared to the current SpeediCath coating.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 2013
Est. primary completion date April 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Have given written informed consent and signed letter of authority

2. Be at least 18 years of age and have full legal capacity

3. Be a male

4. Willing to refrain from using analgetics up to 24 hours prior to catheterization visits

Exclusion Criteria:

1. Abnormalities, diseases or surgical procedures performed in the lower urinary tract

2. Symptoms of urinary tract infections (at least one of the following: frequent urination, stinging or pain at urination)

3. Participating in other interventional clinical investigations during this investigation (inclusion to termination) or have previously participated in this investigation (including run-in period)

4. Known hypersensitivity toward any of the test products -

Study Design


Related Conditions & MeSH terms

  • Intermittent Urethral Catheterization

Intervention

Device:
ZN-D catheter
ZN-D catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.
ZN-C catheter
ZN-C catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.
SpeediCath catheter
The Speedicath cathere is CE-marked and commercially available.

Locations

Country Name City State
Denmark Department of Urology Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Coloplast A/S

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Discomfort During Catheterization Evaluated by the subject on a 10 cm Visual Analog Scale (VAS), where 0 cm is no discomfort and 10 cm is the worst possible discomfort. 1 day
See also
  Status Clinical Trial Phase
Completed NCT02911051 - Clinical Study Evaluating the Safety of a New Catheter for Urinary Intermittent Catheterization in Self Catheterized Patients N/A
Completed NCT04033913 - What Are the Criteria for the Patient's Choice of Sel-catheterization Catheter
Active, not recruiting NCT04763382 - The Effect of Nursing Interventions for Clean Intermittent Catheterization Caregivers and Child N/A
Completed NCT02129738 - Reuse of Intermittent Urethral Catheters N/A
Completed NCT04095871 - Determinants, Impact and Adherence Related to the Duration of Performing Self Catheterization on Patient Satisfaction and Quality of Life
Completed NCT03684941 - Evaluation of a New Catheter Coating Process for Urinary Catheters Used for Intermittent Catheterization. N/A